ACADIA Pharmaceuticals fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
08/06/2025 | ACAD | ACADIA Pharmaceuticals | FY | 2025 | — | — | — | $1.04B | $1.09B | $1.06B | |
05/07/2025 | ACAD | ACADIA Pharmaceuticals | FY | 2025 | — | — | — | $1.03B | $1.09B | $1.06B | |
02/26/2025 | ACAD | ACADIA Pharmaceuticals | FY | 2025 | — | — | — | $1.03B | $1.09B | $1.05B | |
11/06/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $940.00M | $960.00M | $952.48M | |
08/06/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $930.00M | $980.00M | $953.15M | |
05/08/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $930.00M | $1.01B | $966.61M | |
02/27/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $930.00M | $1.01B | $965.09M | |
05/08/2023 | ACAD | ACADIA Pharmaceuticals | FY | 2023 | — | — | — | $520.00M | $550.00M | $556.45M | |
02/27/2023 | ACAD | ACADIA Pharmaceuticals | FY | 2023 | — | — | — | $520.00M | $550.00M | $569.16M | |
11/02/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $520.00M | $530.69M | |
08/08/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $540.00M | $531.12M | |
05/04/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $560.00M | $540.68M | |
02/28/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $560.00M | $564.20M | |
11/08/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $480.00M | $500.00M | $490.42M | |
08/04/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $480.00M | $515.00M | $521.79M | |
05/05/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $510.00M | $550.00M | $535.93M |
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di ACADIA Pharmaceuticals.
Sfoglia guidance e previsioni su tutte le azioni.